Top compounds associated with response to NOL4L


Feature Type Standardized
Nominal ANOVA
mRNA LY317615 GDSC1000 pan-cancer AAC 0.094 0.006
mRNA rigosertib CTRPv2 pan-cancer AAC -0.092 0.006
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.096 0.006
mRNA FK866 GDSC1000 pan-cancer AAC 0.083 0.007
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.007
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.087 0.007
mRNA phloretin CTRPv2 pan-cancer AAC -0.094 0.008
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.008
mRNA PD318088 CTRPv2 pan-cancer AAC 0.094 0.009
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.099 0.009
Download CSV